Literature DB >> 26721892

Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.

Nadine J A Mattheij1, Frauke Swieringa1, Tom G Mastenbroek1, Michelle A Berny-Lang2, Frauke May3, Constance C F M J Baaten1, Paola E J van der Meijden1, Yvonne M C Henskens4, Erik A M Beckers5, Dennis P L Suylen1, Marc W Nolte3, Tilman M Hackeng1, Owen J T McCarty2, Johan W M Heemskerk1, Judith M E M Cosemans6.   

Abstract

Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26721892      PMCID: PMC5004391          DOI: 10.3324/haematol.2015.131441

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  38 in total

1.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 2.  Coated-platelets: an emerging component of the procoagulant response.

Authors:  G L Dale
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

3.  Fibrinogen binding to the integrin alpha(IIb)beta(3) modulates store-mediated calcium entry in human platelets.

Authors:  J A Rosado; E M Meijer; K Hamulyak; I Novakova; J W Heemskerk; S O Sage
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction.

Authors:  Calin I Prodan; Julie A Stoner; Linda D Cowan; George L Dale
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

5.  Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.

Authors:  Camilla Lund Nikolajsen; Thomas F Dyrlund; Ebbe Toftgaard Poulsen; Jan J Enghild; Carsten Scavenius
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

6.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

7.  Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen.

Authors:  Karen Gilio; Matthew T Harper; Judith M E M Cosemans; Olga Konopatskaya; Imke C A Munnix; Lenneke Prinzen; Michael Leitges; Qinghang Liu; Jeffery D Molkentin; Johan W M Heemskerk; Alastair W Poole
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

8.  A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa.

Authors:  Fredda S London; Mariola Marcinkiewicz; Peter N Walsh
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

Review 9.  The effects of arterial flow on platelet activation, thrombus growth, and stabilization.

Authors:  Judith M E M Cosemans; Anne Angelillo-Scherrer; Nadine J A Mattheij; Johan W M Heemskerk
Journal:  Cardiovasc Res       Date:  2013-05-10       Impact factor: 10.787

10.  Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice.

Authors:  Kristof Vanschoonbeek; Kristiaan Wouters; Paola E J van der Meijden; Patrick J van Gorp; Marion A H Feijge; Marjolein Herfs; Leon J Schurgers; Marten H Hofker; Moniek P M de Maat; Johan W M Heemskerk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-28       Impact factor: 8.311

View more
  19 in total

1.  Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.

Authors:  Sravya Kattula; James R Byrnes; Sara M Martin; Lori A Holle; Brian C Cooley; Matthew J Flick; Alisa S Wolberg
Journal:  Blood Adv       Date:  2018-01-03

Review 2.  CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.

Authors:  Moua Yang; Roy L Silverstein
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.218

Review 3.  Platelet Subtypes in Inflammatory Settings.

Authors:  Muataz Ali Hamad; Krystin Krauel; Nancy Schanze; Nadine Gauchel; Peter Stachon; Thomas Nuehrenberg; Mark Zurek; Daniel Duerschmied
Journal:  Front Cardiovasc Med       Date:  2022-04-07

4.  Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol.

Authors:  Anna Linnea Södergren; Sofia Ramström
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

5.  Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.

Authors:  Amanda J Unsworth; Alexander P Bye; Dionne S Tannetta; Michael J R Desborough; Neline Kriek; Tanya Sage; Harriet E Allan; Marilena Crescente; Parveen Yaqoob; Timothy D Warner; Chris I Jones; Jonathan M Gibbins
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-15       Impact factor: 8.311

Review 6.  Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo.

Authors:  Thomas M Jeitner; John T Pinto; Arthur J L Cooper
Journal:  Biosci Rep       Date:  2018-09-05       Impact factor: 3.840

7.  Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.

Authors:  Stella Thomassen; Tom G Mastenbroek; Frauke Swieringa; Kristien Winckers; Marion A H Feijge; Roy Schrijver; Judith M E M Cosemans; Susan A Maroney; Alan E Mast; Tilman M Hackeng; Johan W M Heemskerk
Journal:  Thromb Haemost       Date:  2018-02-16       Impact factor: 5.249

Review 8.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05

Review 9.  Interplay between platelets and coagulation.

Authors:  Yaqiu Sang; Mark Roest; Bas de Laat; Philip G de Groot; Dana Huskens
Journal:  Blood Rev       Date:  2020-07-12       Impact factor: 10.626

Review 10.  Integrating platelet and coagulation activation in fibrin clot formation.

Authors:  Frauke Swieringa; Henri M H Spronk; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Res Pract Thromb Haemost       Date:  2018-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.